Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment.
Tom TencerOliver WillJinender KumarM Janelle Cambron-MellottdeMauri S MackieKathleen BeusterienPublished in: Current medical research and opinion (2021)
This study highlights similarities in treatment preferences for non-highly-active RRMS among patients and neurologists and differences in neurologists' preferences for treating non-highly-active vs. highly active RRMS. This research identifies BVL as a treatment outcome that should be discussed when physicians engage in shared decision-making with patients.
Keyphrases
- multiple sclerosis
- end stage renal disease
- decision making
- ejection fraction
- newly diagnosed
- primary care
- white matter
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- case report
- genome wide
- gene expression
- systemic lupus erythematosus
- patient reported outcomes
- dna methylation
- replacement therapy
- patient reported